| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |